SL-1 Activity on Nationwide Cancer Genome Screening Project for Advanced Solid Tumors; SCRUM-Japan GI-/MONSTAR-SCREEN

Advances in precision oncology have made genotyping mandatory for most advanced solid tumors to ensure proper therapy selection. However, the innovations remains limited by the realities of patient identification-actionable targets are present in only a small fraction of patients. We initiated a nat...

Descripción completa

Detalles Bibliográficos
Autor principal: Yoshino, Takayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Supplement Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699086/
http://dx.doi.org/10.1093/noajnl/vdaa143.000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699086/
http://dx.doi.org/10.1093/noajnl/vdaa143.000

Ejemplares similares